K.‐O. Habermehl

936 citations
31 papers · 751 indexed · h-index 12

K.‐O. Habermehl

30 papers receiving 676 citations

Peers

K.‐O. Habermehl
Comparison fields: 5 of 80
  • Cardiology and Cardiovascular Medicine 239
  • Epidemiology 359
  • Infectious Diseases 181
  • Virology 34
  • Animal Science and Zoology 72
Replace F J van Kuppeveld with:
F J van Kuppeveld Netherlands
Steven J. Mento United States
George K. Hirst Albania
R. Nelson United Kingdom
R. G. Marusyk Canada
Yoichiro Kino Japan
Andrew Tuplin United Kingdom
A.S. Grewal India
Lindsey A. Moser United States
S. S. Breese United States
K.‐O. Habermehl relative to F J van Kuppeveld Netherlands F J van Kuppeveld's profile →
Citations per field
00.5×1.5×2.1×
F J van Kuppeveld · 1×
Citations per year

Countries citing papers authored by K.‐O. Habermehl

Since Specialization
Citations

This map shows the geographic impact of K.‐O. Habermehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.‐O. Habermehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.‐O. Habermehl more than expected).

Fields of papers citing papers by K.‐O. Habermehl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.‐O. Habermehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.‐O. Habermehl. The network helps show where K.‐O. Habermehl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside K.‐O. Habermehl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K.‐O. Habermehl Line = papers co-authored together K.‐O. Habermehl links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 19953
2 19924
3 19916
4 19908
5 199065
6 19882
7 198757
8
Autopsiebefunde bei Verstorbenen mit erworbenem Immundefektsyndrom
19861
9 198610
10 19856
11 1985115
12 19841
13 198314
14 19814
15 19815
16 197911
17 197942
18 197729
19 19678
20 19611

About K.‐O. Habermehl

K.‐O. Habermehl is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine and Animal Science and Zoology, having authored 31 papers that have together received 751 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (13 papers), Viral gastroenteritis research and epidemiology (10 papers), Herpesvirus Infections and Treatments (7 papers), Virus-based gene therapy research (6 papers), Plant Virus Research Studies (6 papers), Bacteriophages and microbial interactions (4 papers), Animal Virus Infections Studies (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (239 citations), Epidemiology (359 citations) and Infectious Diseases (181 citations). K.‐O. Habermehl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include H. Hampl, K. Wetz, Heinz Zeichhardt, Peter Willingmann, Albert S. Kaplan, Tamar Ben‐Porat, Michaël Otto, M A McKinlay, Tom Beneke and Malte Buchholz.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026